Determination of the Effective Volume of 0.125% Bupivacaine-fentanyl 5mcg/mL in Labour Epidurals
Information source: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: Bupivacaine-fentanyl (Drug); Lidocaine (Drug)
Phase: N/A
Status: Completed
Sponsored by: Samuel Lunenfeld Research Institute, Mount Sinai Hospital Official(s) and/or principal investigator(s): Jose CA Carvalho, MD, Principal Investigator, Affiliation: Mount Sinai Hospital, New York
Summary
Different medications can be used as analgesics in labor epidurals. Bupivacaine is one of
the most commonly used drugs for that purpose. The efficacy of a certain medication injected
epidurally depends on the dose that is given. A certain dose can be administered in
different concentrations, which will consequently mean different volumes. Studies have been
done to determine volumes for different concentrations of bupivacaine. However, those
studies fall short in the sense that this information cannot be readily applicable in
clinical practice, as we don't use bupivacaine plain. The combination of bupivacaine and
fentanyl or sufentanil is common practice, as it is well established that the opioids will
reduce the concentration of local anesthetic required to produce optimal effect with the
least side effects.
This study is being planned to determine and compare the EV90 of the bupivacaine
0. 125%-fentanyl mixture for initiation of labor epidural analgesia, following the
administration of the 2 different test doses (3cc of lidocaine 2% or 3cc of the bupivacaine
0. 125%-fentanyl mixture) used in our Department.
Clinical Details
Official title: Determination of the Effective Volume of the 0.125% Bupivacaine-fentanyl 5mcg/mL Mixture Used for Epidural Analgesia in Labor
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: VNRS pain score
Secondary outcome: Dermatome sensory levelMotor block Hypotension
Detailed description:
Epidural administration of local anesthetics during labor produces analgesia, sympathetic
block and motor block. The characteristics of the block depend on the volume and
concentration of the local anesthetic that is used as well as the use of adjuncts(in our
case: Fentanyl). Although many researchers have investigated the efficacy of different drugs
at different concentrations, the volumes used have been arbitrary. There is limited data
regarding the minimum volume that is necessary for a successful anesthetic for a given
concentration of bupivacaine.
This study is conducted as a prospective, randomized, up-down sequential allocation trial.
The aim is to determine the minimum volume of 0. 125% bupivacaine in combination with
5mcgr/ml fentanyl that will provide effective analgesia for 90% of parturients in the first
stage of labor. The verbal numeric rating scale (VNRS) is used to rate the pain felt over
the first 20 minutes, where 0 is no pain and 10 is the worst pain imaginable. After 20
minutes, if the VNRS was greater than 1, the volume of the bupivacaine/fentanyl mixture was
considered inadequate and additional volume of the mixture will be given.
After the randomised test dose of either 3cc lidocaine 2% or 3cc of the bupivacaine/fentanyl
mixture is given, the loading volume of the bupivacaine/fentanyl mixture will be given. The
volume of the bupivacaine/fentanyl mixture for the first patient was chosen at 10 ml (This
is the volume with which is generally started in standard practice), and the dose for each
subsequent patient depends on the outcome of the previous injection. Doses will be increased
or decreased in increments of 2 ml. If the previous response was ineffective, the next
patient will receive 2 ml more than the last patient. If the response of the previous
patient is effective, the biased coin up-and-down allocation design, which is used to
cluster doses around EV90, will be applied to determine if the dose remains the same or
decreases.
40 patients will be included in each group within the study. The target volume, EV90, which
is defined as the volume at which adequate response would occur in 90% of patients, will be
estimated for each of the two test dose groups using Dixon and Mood method. The 95%
confidence interval of EV90s will be estimated and based in comparing the EV90 between two
groups. Isotonic Regression method will also be conducted to assess the EV90s. The side
effects will also be summarized by the volume levels descriptively.
Eligibility
Minimum age: 18 Years.
Maximum age: 55 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- ASA I or II
- Full term (minimum 37 weeks gestation)
- Singleton pregnancy, vertex presentation
- Regular painful contractions occurring at least every 5 minutes
- VAS Pain score at requesting analgesia > 5 (VNPS 0-10)
- Cervical dilatation < 5 cm
Exclusion Criteria:
- Refusal to provide written informed consent.
- Any contraindication to epidural anesthesia
- Accidental dural puncture
- Allergy or hypersensitivity to bupivacaine or fentanyl
- Use of opioids or sedatives within the last 4 hours.
Locations and Contacts
Mount Sinai Hospital, Toronto, Ontario M5G1X5, Canada
Additional Information
Starting date: October 2013
Last updated: June 3, 2014
|